The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial. (2014)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/1745-6215-15-371

PubMed Identifier: 25252600

Publication URI: http://europepmc.org/abstract/MED/25252600

Type: Journal Article/Review

Volume: 15

Parent Publication: Trials

ISSN: 1745-6215